Skip to content

Study · Non-randomized trial · n = 41 · 1996

8 results

Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study.

Hamamci N, Dursun E, Ural C, Cakci A

The British journal of clinical practice1 Oct 1996Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study8

8 results from studies that gave the peptide. 8 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, salmon calcitonin reduced pain scores versus saline.

    In plain wordsIn hemiplegic patients with reflex sympathetic dystrophy, salmon calcitonin reduced pain scores versus saline.

    Outcome
    DecreasePain score
    Study

    n = 41

    Comparator
    Physiological saline
    Outcome group
    Pain · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    At the end of the fourth week of treatment the pain score of the calcitonin group was significantly lower than that of the control group.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  2. 02HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, shoulder abduction was significantly better in the salmon calcitonin group than in the saline control group.

    In plain wordsIn hemiplegic patients with reflex sympathetic dystrophy, shoulder abduction was better with salmon calcitonin than with saline.

    Outcome
    Direction not reportedShoulder abduction
    Study

    n = 41

    Comparator
    Physiological saline
    Outcome group
    Exercise and physical function · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    Shoulder abduction and external rotation, wrist flexion and metacarpophalangeal extension of the calcitonin group were found to be significantly better than those of the control group.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  3. 03HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, salmon calcitonin improved shoulder external rotation versus saline.

    In plain wordsIn hemiplegic patients, salmon calcitonin improved shoulder external rotation versus saline.

    Outcome
    IncreaseShoulder external rotation
    Study

    n = 41

    Comparator
    Physiological saline
    Outcome group
    Exercise and physical function · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    Shoulder abduction and external rotation, wrist flexion and metacarpophalangeal extension of the calcitonin group were found to be significantly better than those of the control group.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  4. 04HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, salmon calcitonin improved wrist flexion versus saline.

    In plain wordsIn hemiplegic patients, salmon calcitonin improved wrist flexion versus saline.

    Outcome
    IncreaseWrist flexion
    Study

    n = 41

    Comparator
    Physiological saline
    Outcome group
    Exercise and physical function · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    Shoulder abduction and external rotation, wrist flexion and metacarpophalangeal extension of the calcitonin group were found to be significantly better than those of the control group.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  5. 05HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, salmon calcitonin improved metacarpophalangeal extension versus saline.

    In plain wordsIn hemiplegic patients, salmon calcitonin improved finger joint extension versus saline.

    Outcome
    IncreaseMetacarpophalangeal extension
    Study

    n = 41

    Comparator
    Physiological saline
    Outcome group
    Exercise and physical function · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    Shoulder abduction and external rotation, wrist flexion and metacarpophalangeal extension of the calcitonin group were found to be significantly better than those of the control group.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  6. 06HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, tenderness decreased significantly during salmon calcitonin treatment.

    In plain wordsIn hemiplegic patients, tenderness decreased significantly during salmon calcitonin treatment.

    Outcome
    DecreaseTenderness
    Study

    n = 25

    Outcome group
    Pain · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    In the calcitonin group the significant decrease in pain and tenderness resulted in improvement of range of motion and motor functions.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  7. 07HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, motor functions improved during salmon calcitonin treatment.

    In plain wordsIn hemiplegic patients, motor functions improved during salmon calcitonin treatment.

    Outcome
    Direction not reportedMotor functions
    Study

    n = 25

    Outcome group
    Exercise and physical function · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    In the calcitonin group the significant decrease in pain and tenderness resulted in improvement of range of motion and motor functions.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).
  8. 08HumanNon-randomized trialEfficacy outcome

    In hemiplegic patients with reflex sympathetic dystrophy, pain decreased significantly during salmon calcitonin treatment.

    In plain wordsIn hemiplegic patients with reflex sympathetic dystrophy, pain decreased significantly during salmon calcitonin treatment.

    Outcome
    DecreasePain during treatment
    Study

    n = 25

    Outcome group
    Pain · Musculoskeletal
    Studied dose
    100 IU/day · intramuscular · 4 weeksAs given in this study (human).

    Source sentences

    Summary
    In the calcitonin group the significant decrease in pain and tenderness resulted in improvement of range of motion and motor functions.
    2 context sentences
    Summary · context
    Forty-one patients with hemiplegia resulting from cerebrovascular events and stage 1-2 reflex sympathetic dystrophy were included in the study.
    Summary · context
    Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks, was administered to 25 of these patients (calcitonin group) to the other 16 patients physiological saline, 1 ml/day intramuscularly for 4 weeks, was administered (control group).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.